Seeking Alpha

Biotech Analysis Central Model 10+ Portfolio Pick #1 Aldeyra Therapeutuics; NDA Resubmission Reproxalap Plus Phase 2 Data Alcoholic Hepatitis 2nd Half Of 2024, Cash Beyond 2026 ...

The next article I wanted to discuss for the Biotech Analysis Central Model 10+ Portfolio Pick #1 is a biotech by the name of Aldeyra Therapeutics (ALDX). The reason why i want to go over this biotech ...
Seeking Alpha

Biotech Analysis Central Model 10+ Portfolio Pick #7 Iovance Biotherapeutics; Surge In AMTAGVI Revenue, Lifileucel NSCLC Data 2025, Regulatory Filing 2026 And Catalysts

The next article I wanted to discuss for the Biotech Analysis Central Model 10+ Portfolio Pick #7 is a biotech by the name of Iovance Biotherapeutics (IOVA). The reason why I believe it is important ...
Yahoo Finance

Scorpius Holdings Launches Scorpius Ventures to Support U.S. Biotech Innovation through Flexible Equity-Based Onshoring Model

DURHAM, N.C., Nov. 19, 2024 (GLOBE NEWSWIRE) -- Scorpius Holdings, Inc (NYSE American: SCPX) ("Scorpius" or "the Company"), an integrated contract development and manufacturing organization ("CDMO"), ...